Please login to the form below

Not currently logged in
Email:
Password:

EFPIA

This page shows the latest EFPIA news and features for those working in and with pharma, biotech and healthcare.

Industry aghast as EU Parliament backs biosimilar rule change

Industry aghast as EU Parliament backs biosimilar rule change

In an open letter to European institutions, the president of the EFPIA trade body, Merck KGaA chairman and CEO Stefan Oschmann (below), says the EP’s provisions “diverge significantly from the

Latest news

More from news
Approximately 33 fully matching, plus 149 partially matching documents found.

Latest Intelligence

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Life science companies, the ABPI and EFPIA have been clear that the UK and the EU need to provide businesses with ‘certainty’ so that they are able to create contingency plans

  • Brexit Means Brexit Brexit Means Brexit

    These common-sense ambitions are broadly aligned with those of EFPIA and pharmaceutical companies across Europe.

  • A quest for innovative solutions A quest for innovative solutions

    Increase returns. UCB is one of the partners in a consortium that includes other EFPIA companies, universities, research organisations, public bodies, non-profit groups and other third parties.

  • Healthcare systems

  • The sound of silence puts the squeeze on generics and biosimilars The sound of silence puts the squeeze on generics and biosimilars

    Fair proposal. He believes lobbying by the European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents 33 national associations and 42 leading pharmaceutical companies, is blocking a revenue stream and ... EFPIA issued a

More from intelligence
Approximately 6 fully matching, plus 27 partially matching documents found.

Latest appointments

  • EFPIA appoints new director general EFPIA appoints new director general

    Joe Jiminez, president of EFPIA, said: “Nathalie has an excellent track record of leadership and engagement across the life science sector. ... We are confident she is the right person to lead EFPIA, working with stakeholders to address the challenges

  • IFPMA appoints director general IFPMA appoints director general

    Thomas Cueni brings expertise from Interpharma and EFPIA. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has selected Thomas Cueni as its new director general. ... Cueni also brings industry expertise from the

  • Bayer appoints president of Americas pharma business Bayer appoints president of Americas pharma business

    He also brings branding and sales leadership experience from Novar tis and Eli Lilly, and recently served as chairman of European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan.

  • Eric Cornut appointed EFPIA interim director general Eric Cornut appointed EFPIA interim director general

    Currently an independent consultant based in Basel, Switzerland, Cornut brings over 25 years of pharmaceutical management experience to the role, including five years as chairman of EFPIA's executive committee. ... work. “I am very pleased that Eric

  • EFPIA director general Richard Bergström resigns EFPIA director general Richard Bergström resigns

    Richard Bergström, director general of The European Federation of the Pharmaceutical Industries and Associates (EFPIA), has resigned his post. ... Described by the EFPIA's president Joe Jimenez as “the voice of the pharmaceutical industry in Europe

More from appointments
Approximately 7 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • The changing face of medical communications over the past 15 years

    Similarly, the launch of Disclosure UK’s searchable database, which went live in June 2016, is a helpful development for the UK (and Europe-wide through EFPIA), although details don’t

  • How Transparent Is Transparency?

    So, what have we learnt? Is the  EFPIA  mission – to provide a greater understanding of the merits and ethics of the interactions between pharmaceutical companies and healthcare professionals (HCPs) – bearing any ... The EFPIA vision of enhanced

  • Brexit and Pharma: A match made in hell.

    My husband and I woke up in the early hours of 24 June 2016 to the astonishing news that the UK had voted to leave the EU. It’s fair to say both of us shuddered and, while our perspectives were different, our concerns with regard to the complexity

  • Compliance Hub Ltd

    Specialists in ABPI, ABHI and EFPIA codes of practice - provides training, audit and consultancy services.

  • Cameron Medical Communications Ltd

    We specialise in: Marketing Codes of Practice, ABPI, EFPIA, IFPMA, Medical Information Systems and Services and Copyright.

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics